293 related articles for article (PubMed ID: 15994946)
1. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
Xu L; Tong R; Cochran DM; Jain RK
Cancer Res; 2005 Jul; 65(13):5711-9. PubMed ID: 15994946
[TBL] [Abstract][Full Text] [Related]
2. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression.
Wang W; Qi L; Tan M; Zhang Z; Du J; Wei X; Yao X
Urol Oncol; 2015 Apr; 33(4):168.e17-27. PubMed ID: 25766258
[TBL] [Abstract][Full Text] [Related]
5. [Effect of platelet derived growth factor-B and its receptor expression on the proliferation of renal cell carcinoma ACHN cells].
Wang W; Zhang Z; Wang S; Du J; Yao X
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):170-4. PubMed ID: 25975783
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities.
Borkham-Kamphorst E; Alexi P; Tihaa L; Haas U; Weiskirchen R
Biochem Biophys Res Commun; 2015 Feb; 457(3):307-13. PubMed ID: 25576870
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
Hwang RF; Yokoi K; Bucana CD; Tsan R; Killion JJ; Evans DB; Fidler IJ
Clin Cancer Res; 2003 Dec; 9(17):6534-44. PubMed ID: 14695158
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
[TBL] [Abstract][Full Text] [Related]
11. Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines.
Apte SM; Bucana CD; Killion JJ; Gershenson DM; Fidler IJ
Gynecol Oncol; 2004 Apr; 93(1):78-86. PubMed ID: 15047217
[TBL] [Abstract][Full Text] [Related]
12. PDGF-D signaling: a novel target in cancer therapy.
Wang Z; Kong D; Li Y; Sarkar FH
Curr Drug Targets; 2009 Jan; 10(1):38-41. PubMed ID: 19149534
[TBL] [Abstract][Full Text] [Related]
13. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
14. Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer.
Reinmuth N; Liersch R; Raedel M; Fehrmann F; Fehrmann N; Bayer M; Schwoeppe C; Kessler T; Berdel W; Thomas M; Mesters RM
Int J Cancer; 2009 Apr; 124(7):1535-44. PubMed ID: 19115205
[TBL] [Abstract][Full Text] [Related]
15. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
[TBL] [Abstract][Full Text] [Related]
16. A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth.
Huang W; Fridman Y; Bonfil RD; Ustach CV; Conley-LaComb MK; Wiesner C; Saliganan A; Cher ML; Kim HR
Oncogene; 2012 Oct; 31(42):4527-35. PubMed ID: 22158043
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of platelet-derived growth factor-D promotes tumor growth and invasion in endometrial cancer.
Wang Y; Qiu H; Hu W; Li S; Yu J
Int J Mol Sci; 2014 Mar; 15(3):4780-94. PubMed ID: 24646915
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells.
Kong D; Banerjee S; Huang W; Li Y; Wang Z; Kim HR; Sarkar FH
Cancer Res; 2008 Mar; 68(6):1927-34. PubMed ID: 18339874
[TBL] [Abstract][Full Text] [Related]
19. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer.
Liu J; Liao S; Huang Y; Samuel R; Shi T; Naxerova K; Huang P; Kamoun W; Jain RK; Fukumura D; Xu L
Clin Cancer Res; 2011 Jun; 17(11):3638-48. PubMed ID: 21459800
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer.
LaRochelle WJ; Jeffers M; Corvalan JR; Jia XC; Feng X; Vanegas S; Vickroy JD; Yang XD; Chen F; Gazit G; Mayotte J; Macaluso J; Rittman B; Wu F; Dhanabal M; Herrmann J; Lichenstein HS
Cancer Res; 2002 May; 62(9):2468-73. PubMed ID: 11980634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
